Streetbeat News

AMWL

American Well Corporation

Industry

Medical - Healthcare Information Services

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Open

9.95

Mkt cap

155M

Volume

41K

High

10.12

P/E Ratio

-0.72

52-wk high

21.60

Low

9.80

Div yield

N/A

52-wk low

5.00

Amwell has granted RSUs covering 16,737 shares of its Class A common stock to four new employees as an inducement to join the company.

Portfolio Pulse from

February 21, 2025 | 2:45 pm

Amwell (NYSE: AMWL), a provider of a SaaS-based healthcare platform, will participate in an upcoming investor conference.

Portfolio Pulse from

February 19, 2025 | 9:30 pm

American Well Corporation (AMWL) held its Q4 2024 earnings call on February 12, 2025. Key participants included executives and analysts from major financial institutions.

Portfolio Pulse from

February 13, 2025 | 4:30 am

American Well (AMWL) reported its Q4 earnings, with a focus on how key metrics compared to Wall Street estimates and the previous year's figures.

Portfolio Pulse from

February 13, 2025 | 1:45 am

American Well Corporation (AMWL) reported a Q4 loss of $2.77 per share, which was better than the Zacks Consensus Estimate of a $2.82 loss. This is an improvement from the $3.40 loss per share reported a year ago.

Portfolio Pulse from

February 13, 2025 | 12:00 am

Amwell (NYSE: AMWL) released its financial results for Q4 and full year 2024, highlighting its performance as a leading SaaS-based healthcare platform provider.

Portfolio Pulse from

February 12, 2025 | 9:15 pm

American Well (AMWL) is set to release its Q4 earnings for the quarter ended December 2024. Investors are advised to look beyond the headline estimates and consider key metrics for a comprehensive understanding of the company's performance.

Portfolio Pulse from

February 11, 2025 | 3:30 pm

Amwell (NYSE: AMWL) is set to release its fourth quarter and full year 2024 operating results on February 12, 2025, after market hours. Investors will be keen to assess the company's performance in the digital care sector.

Portfolio Pulse from

January 29, 2025 | 12:15 pm

Amwell has sold its virtual psychiatric care business, Amwell Psychiatric Care, to Avel eCare in an all-cash transaction. This divestment is part of Amwell's strategy to focus on key growth initiatives and improve efficiencies. The company has reiterated its guidance for 2024.

Portfolio Pulse from

January 09, 2025 | 1:15 pm

Amwell has announced that its CFO, Mark Hirschhorn, will expand his role to include Chief Operating Officer responsibilities, overseeing operational and growth strategies.

Portfolio Pulse from

December 18, 2024 | 9:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.